Exhibit 99.2 to IntriCon Corporation Form 8-K dated July 24, 2006

ST. PAUL, Minn. — July 24, 2007 — IntriCon Corporation (AMEX: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature medical and electronics products, today announced financial results for its 2007 second quarter ended June 30, 2007.

For the second quarter, the company reported net sales of $16.9 million, a 28 percent increase from sales of $13.2 million for the 2006 second quarter. IntriCon delivered second-quarter net income of $527,000, or $0.10 per diluted share. This is a 20 percent increase from net income of $424,000, or $0.08 per diluted share, for the 2006 second quarter. The 2007 sales and net income include approximately one month of results from the late-May 2007 acquisition of Tibbetts Industries, Inc.

“Our medical business continues to perform very well, driven by increasing OEM demand for miniature, body-worn devices,” said Mark S. Gorder, president and chief executive officer of IntriCon. “Also contributing to second-quarter results were significant gains in hearing health and professional audio. Combined, our core medical, hearing-health and professional audio businesses delivered top-line, second-quarter growth of 38 percent.”

For the six-month period, IntriCon reported sales of $31.5 million and net income of $554,000, or $0.10 per diluted share. This compares to 2006 six-month sales of $25.0 million and net income of $282,000, or $0.05 per diluted share.

During the second quarter, IntriCon announced that it secured $14.5 million in new senior credit facilities with LaSalle Bank to finance the purchase of Tibbetts Industries, refinance existing debt and meet working capital requirements. Second-quarter and six-month results contain a $180,000, or $0.03 per diluted share, charge related to the refinancing of the credit facility. Management believes the favorable new terms will enhance IntriCon’s financial flexibility and strengthen the company in both the short- and long-term.

Excluding the impact of Tibbetts, IntriCon reported 2007 second-quarter net sales of $16.1 million and net income of $563,000, or $0.10 per diluted share. Again, excluding Tibbetts, net sales totaled $30.7 million for the six-month period with net income of $590,000, or $0.11 per diluted share.

For the second quarter, IntriCon’s core businesses increased 38 percent year-over-year. The company’s non-core electronics business decreased 10 percent from the second quarter of 2006.

Said Gorder, “The addition of Tibbetts provides us with significant incremental gains in both our medical and professional audio businesses. We believe the benefits of this acquisition will eventually carry over to hearing health, where we expect to incorporate Tibbetts’ pioneering magnetic telecoil and miniature transducer technology into key hearing aid components.

“Tibbetts’ surveillance capabilities also expand our markets to include security products—which are reflected in our professional audio performance. Security products, though currently a small percentage of our overall business, are seeing increasing demand in today’s post-9/11 climate.”

According to Gorder, IntriCon’s growth strategies also potentially include further acquisitions that are consistent with the company’s mission. In addition, IntriCon will work to accelerate new product development, further commit to research and development initiatives, and incorporate proprietary technology in all devices.

Concluded Gorder, “Our strategic, core-market focus on high-tech, body-worn devices is proving effective from both a top- and bottom-line perspective. By launching new products that use proprietary IntriCon design and technology, we believe we’re creating new opportunities and driving the business forward.”

Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature medical and electronics products. The company is focused on four key markets: medical, hearing health, professional audio and communications, and electronics. IntriCon has facilities in the United States, Asia and Europe. The company’s common stock trades under the symbol “IIN” on the American Stock Exchange. For more information about IntriCon, visit www.intricon.com.

Statements made in this release and in IntriCon’s other public filings and releases that are not historical facts or that include forward-looking terminology such as “may”, “will”, “believe”, “expect”, “should”, “optimistic” or “continue” or the negative thereof or other variations thereon are “forward-looking statements” within the meaning of the Securities Exchange Act of 1934 as amended. These forward-looking statements include, without limitation, statements concerning the benefits of the new credit facility and the Tibbetts acquisition, future growth and expansion,

future financial condition and performance, prospects, and the positioning of IntriCon to compete in chosen markets. These forward-looking statements are affected by known and unknown risks, uncertainties and other factors that are beyond IntriCon’s control, and may cause IntriCon’s actual results, performance or achievements to differ materially from the results, performance and achievements expressed or implied in the forward-looking statements. These risks, uncertainties and factors include, without limitation, risks related to the Tibbetts acquisition, including unanticipated liabilities and expenses, the risk that IntriCon may not be able to achieve its long-term strategy, weakening demand for products of the company due to general economic conditions, possible non-performance of developing technological products, the volume and timing of orders received by the company, changes in the mix of products sold, competitive pricing pressures, availability of electronic components for the company’s products, ability to create and market products in a timely manner, competition by competitors with more resources than the company, foreign currency risks arising from the company’s foreign operations and other risks detailed from time to time in the company’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2006. The company disclaims any intent or obligation to publicly update or revise any forward-looking statements, regardless of whether new information becomes available, future developments occur or otherwise.

	Three Months Ended
	June 30, 2007			June 30, 2006
Sales, net	$	16,937,697		$	13,208,492

Costs of sales		12,731,182			9,689,188

Gross profit		4,206,515			3,519,304

Operating expenses:
Selling expense		962,872			869,111
General and administrative expense (a)		1,613,217			1,321,397
Research and development expense		650,777			611,838
Total operating expenses		3,226,866			2,802,346

Operating income		979,649			716,958

Interest expense		(333,129	)		(144,649	)
Interest income		12,047			17,747
Equity in loss of partnership		(60,000	)		—
Other income (expense), net		35,788			(28,758	)
Income before income taxes		634,355			561,298
Income tax expense		107,511			112,931
Income from continuing operations		526,844			448,367
Loss from discontinued operations, net of income tax expense		—			(25,876	)

Net income	$	526,844		$	422,491

Income (loss) per share:
Basic
Continuing operations	$	.10		$	.09
Discontinued operations		—			(.01	)
	$	.10		$	.08

Diluted
Continuing operations	$	.10		$	.08
Discontinued operations		—			(.00	)
	$	.10		$	.08

Average shares outstanding:
Basic		5,200,137			5,155,425
Diluted		5,455,743			5,462,396

	Six Months Ended
	June 30, 2007			June 30, 2006
Sales, net	$	31,516,964		$	25,044,626

Costs of sales		24,099,192			18,758,911

Gross profit		7,417,772			6,285,715

Operating expenses:
Selling expense		1,805,638			1,771,532
General and administrative expense (a)		3,033,481			2,626,806
Research and development expense		1,383,458			1,180,821
Total operating expenses		6,222,577			5,579,159

Operating income		1,195,195			706,556

Interest expense		(486,406	)		(301,176	)
Interest income		50,783			39,640
Equity in loss of partnership		(80,000	)		—
Other income (expense), net		10,051			(60,944	)
Income before income taxes		689,623			384,076
Income tax expense		135,271			75,018
Income from continuing operations		554,352			309,058
Loss from discontinued operations, net of income tax expense		—			(27,975	)

Net income	$	554,352		$	281,083


Income (loss) per share:
Basic
Continuing operations	$	.11		$	.06
Discontinued operations		—			(.01	)
	$	.11		$	.05

Diluted
Continuing operations	$	.10		$	.06
Discontinued operations		—			(.01	)
	$	.10		$	.05

Average shares outstanding:
Basic		5,198,542			5,152,914
Diluted		5,410,192			5,439,651

(a) General and administrative expense includes $141,699 and $93,346 of non-cash stock option expense related to the adoption of FAS 123(R) at June 30, 2007 and 2006, respectively.

Assets	June 30, 2007		December 31, 2006
	(unaudited)
Current assets

Cash	$	1,016,976	$	599,459

Restricted cash		60,158		60,158

Accounts receivable, less allowance for doubtful accounts of $253,000 at 2007 and $246,000 at 2006		9,526,446		8,456,450

Inventories		10,033,727		9,030,615

Refundable income taxes		40,636		103,587

Note receivable from sale of discontinued operations, less allowance of $225,000 at 2007 and 2006		225,000		300,000
Other current assets		364,840		235,418

Total current assets		21,267,783		18,785,687

Property, plant and equipment
Machinery and equipment		36,123,100		28,767,904
Less: accumulated depreciation		27,567,369		21,994,344

Net property, plant and equipment		8,555,731		6,773,560

Long-term note receivable from sale of discontinued operations		—		75,000

Goodwill		7,942,582		5,927,181

Investment in partnership		1,720,000		1,800,000

Other assets, net		1,687,411		920,051

	$	41,173,507	$	34,281,479

Liabilities and Shareholders’ Equity	June 30, 2007			December 31, 2006
	(unaudited)
Current liabilities

Checks written in excess of cash	$	974,522		$	661,756

Current maturities of long-term debt		1,469,403			952,730

Accounts payable		4,282,460			5,161,450

Income taxes payable		125,497			173,810

Deferred gain on building sale		110,084			110,084

Short term partnership payable		260,000			260,000

Other accrued liabilities		3,828,983			3,021,201

Total current liabilities		11,050,949			10,341,031

Long term debt, less current maturities		9,458,234			3,830,461

Other post-retirement benefit obligations		991,500			1,063,744

Long term partnership payable		1,280,000			1,280,000

Note payable, net of current portion (Amecon)		515,720			515,720

Deferred income taxes		79,273			79,273

Accrued pension liability		588,833			628,569

Deferred gain on building sale		880,673			935,715

Total non-current liabilities		13,794,233			8,333,482

Total liabilities		24,845,182			18,674,513


Commitments and contingencies
Shareholders’ equity
Common shares, $1 par; 10,000,000 shares authorized; 5,713,535 and 5,706,235 shares issued; 5,197,781 and 5,190,481 outstanding		5,713,535			5,706,235
Additional paid-in capital		12,490,343			12,339,988

Accumulated deficit		(435,153	)		(989,505	)

Accumulated other comprehensive loss		(175,322	)		(184,674	)

Less: 515,754 common shares held in treasury, at cost		(1,265,078	)		(1,265,078	)

Total shareholders’ equity		16,328,325			15,606,966

	$	41,173,507		$	34,281,479

At IntriCon:	At Padilla Speer Beardsley:
Scott Longval, CFO	Matt Sullivan/Marian Briggs
651-604-9526	612-455-1700
slongval@intricon.com	msullivan@psbpr.com / mbriggs@psbpr.com